WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs

WHO issues updated dosing guidance for antiretroviral medicines used in newborns, infants and children

WHO Director-General meets HIV community leaders to reaffirm commitment to community leadership and meaningful engagement

New WHO report outlines critical steps to confront fungal disease and antifungal resistance

WHO certifies Turks and Caicos for eliminating mother-to-child transmission of HIV and hepatitis B

United to End AIDS: New political declaration launches final push to accelerate progress towards ending AIDS as a public health threat by 2030

WHO applauds South Africa’s leadership in advancing HIV prevention through lenacapavir rollout

WHO certifies the Bahamas for eliminating mother-to-child transmission of HIV

Denmark becomes first country in the European Union to eliminate mother-to-child transmission of HIV and syphilis

WHO launches landmark consolidated operational handbook to strengthen the global STI response amid rising infections

WHO releases updated recommendations on HIV clinical management

End-of-year message from the Director of the WHO’s department for HIV, TB, Hepatitis & STIs

WHO validates Brazil for eliminating mother-to-child transmission of HIV

WHO’s new guidance on maintaining opioid agonist maintenance treatment as an essential health service

Lenacapavir approved in Zambia and Zimbabwe in record time through WHO Collaborative Registration Procedure

New prevention tools and investment in services essential in the fight against AIDS

WHO launches new framework to tackle drug resistance to HIV, hepatitis B and C, and STIs

Maldives becomes the first country to achieve ‘triple elimination’ of mother-to-child transmission of HIV, syphilis and hepatitis B

WHO released updated guideline on HIV service delivery

WHO announces the development of guidelines on multiplex testing